Find NINDS Clinical Trials

Study Title Sort descending Disorders Status Study Location Clinical Trials ID
Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility Multiple Sclerosis Completed Maryland NCT01617395
Relationship Between Sensory and Motor Systems in Restless Leg Syndrome Restless Legs Syndrome Completed Maryland NCT00074672
RNS System LGS Feasibility Study Epilepsy and Seizures Recruiting Multiple U.S. Locations NCT05339126
Rolipram to Treat Multiple Sclerosis Multiple Sclerosis Completed Maryland NCT00011375
Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke Stroke Withdrawn NCT01133223
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Completed Multiple U.S. Locations NCT01982942
Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS) Multiple Sclerosis Completed Maryland NCT00001781
Self System Therapy and Chronic Low Back Pain Trial Completed North Carolina NCT00672880
Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial Migraine, Headache Not Yet Recruiting NCT06170281
Sleep Disorders of Patients With Diseases of the Nervous System Hypersomnia, Narcolepsy Completed Maryland NCT00001664
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development Completed Multiple U.S. Locations NCT01736553
Study of Efficacy of the MyoTrain System in a Population of Individuals With Trans-radial Limb Loss Not Yet Recruiting NCT05888428
Study of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy Completed Maryland NCT02124057
Study of Norepinephrine Levels and Sympathetic Nervous System Activity Completed Maryland NCT00001329
Study of Rifampicin in Multiple System Atrophy Multiple System Atrophy Terminated Multiple U.S. Locations NCT01287221
Temperature Response to a Head-Neck Cooling System Completed Maryland NCT00025987
Tolebrutinib, a Brain-penetrant Bruton s Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis Multiple Sclerosis Recruiting Maryland* NCT04742400
Ultra-Low Field (ULF) Point-of-Care (POC) MRI System for Brain Morphology and Pathology Not Yet Recruiting Maryland* NCT06203626
Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis Multiple Sclerosis Recruiting Washington NCT04688710
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis Completed Maryland NCT00071838